Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-015403

Options or other derivatives

  • President and CEO acquired 179,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Meeker David P President and CEO 2026-02-11 Grant or award · Restricted Stock Units +71,900 71,900 D
Meeker David P President and CEO 2026-02-11 Grant or award · Stock Options (Right to Buy) +107,850 107,850 D
Loading xslF345X05/tm266366-6_4seq1.xml…